Revopsis Therapeutics, Inc.

Revopsis Therapeutics, Inc. is a small business in Springfield, IL registered on SAM.gov to bid on federal contracts. It has won 1 small business R&D award worth $1.9 million through the SBIR and STTR programs since 2024, according to SBIR.gov.

UEI
GQ8PWEY4EMD9
CAGE code
9DSH6
SAM.gov registration
Active

Registration details

Legal business nameRevopsis Therapeutics, Inc.
Unique Entity ID (UEI)GQ8PWEY4EMD9
CAGE code9DSH6
LocationSpringfield, IL
SAM.gov registrationActive through Aug 6, 2027
Business started2022
Primary NAICS code541714: Research and Development in Biotechnology (except Nanobiotechnology)
Websiterevopsis.com

SBIR and STTR awards

Revopsis Therapeutics, Inc. has won 1 small business R&D award worth $1.9 million through the SBIR and STTR programs since 2024, 1 of them Phase II. Funded by NIH.

AwardedAgencyProjectAmount
Sep 30, 2024NIHSBIR Phase II Transformational next generation high affinity trispecific fab protein to address unmet needs in…$1.9 million

Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.

Federal contract history

USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.

NAICS codes Revopsis Therapeutics, Inc. is small under

On its SAM.gov registration, Revopsis Therapeutics, Inc. meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.

  • 541714 Research and Development in Biotechnology (except Nanobiotechnology)

Open contracts in Revopsis Therapeutics, Inc.'s NAICS codes

36 open federal opportunities on SAM.gov use a NAICS code Revopsis Therapeutics, Inc. is small under. These are due soonest.

Get matches like these by email, free →

Similar small businesses

Other small businesses with the same primary NAICS code (541714) that have won federal contracts, starting with Illinois:

Frequently asked questions

What is Revopsis Therapeutics, Inc.'s CAGE code?

Revopsis Therapeutics, Inc.'s CAGE code is 9DSH6. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.

What is Revopsis Therapeutics, Inc.'s UEI?

Revopsis Therapeutics, Inc.'s Unique Entity ID (UEI) is GQ8PWEY4EMD9. SAM.gov assigns the UEI, and it identifies the business across the federal government.

Is Revopsis Therapeutics, Inc.'s SAM.gov registration active?

Yes, as of the latest SAM.gov public data, Revopsis Therapeutics, Inc.'s registration is active through Aug 6, 2027. Registrations are renewed every year.

Is Revopsis Therapeutics, Inc. a small business?

Revopsis Therapeutics, Inc. is registered on SAM.gov as small under 1 NAICS code, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.

Keep going

Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To ask us to remove this page, email hello@fedready.us.